semaglutide glp 1 for weight loss GLP-1s Researchers identify avenue for enhanced
Description
Heterogeneity was assessed using Cochrans Q test and the I statistic
The Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) checklist criteria ( 2.1 Search strategy From the inception to August 1, 2025, we searched four electronic databases for relevant literature: PubMed/MEDLINE, Embase, Cochrane CENTRAL, Web of Science
Injecting Toujeo when you meant to inject a GLP-1 drug could cause severe hypoglycemia, especially at insulin doses
Rapid weight loss, a common effect of GLP-1 use, can result in decreased bone density, heightening the risk of osteoporosis and fractures
